Axonal protective effects of the myelin-associated glycoprotein. [electronic resource]
Producer: 20090408Description: 630-7 p. digitalISSN:- 1529-2401
- Acrylamide -- toxicity
- Action Potentials -- genetics
- Age Factors
- Animals
- Animals, Newborn
- Cells, Cultured
- Cricetinae
- Cricetulus
- Disease Models, Animal
- GPI-Linked Proteins
- Ganglia, Spinal
- In Vitro Techniques
- Mice
- Mice, Inbred C57BL
- Mice, Knockout
- Motor Activity -- drug effects
- Mutagenesis, Site-Directed -- methods
- Myelin Proteins -- deficiency
- Myelin-Associated Glycoprotein -- deficiency
- Nerve Degeneration -- etiology
- Nerve Fibers, Myelinated -- metabolism
- Neural Conduction -- genetics
- Neurofilament Proteins -- metabolism
- Neuroprotective Agents -- therapeutic use
- Nogo Receptor 1
- Phosphoinositide Phospholipase C -- toxicity
- Rats
- Receptors, Cell Surface -- deficiency
- Spinal Cord Injuries -- complications
- Time Factors
- Tubulin -- metabolism
- Tubulin Modulators -- therapeutic use
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.